Search This Blog

1

Labels

Cancer (150) Breast (38) Study (38) Health (32) Patients (31) Treatment (27) Could (23) Therapy (19) Research (17) Against (12) Blood (11) Disease (11) linked (11) Diabetes (10) Early (10) Prevent (10) Survival (10) Treatments (7) higher (7) surgery (7) Might (6) Prostate (6) Tumors (6) During (5) Effects (5) Growth (5) Chemotherapy (4) Drinking (4) Prevention (4) Obama (3) Obesity (3) Without (3) associated (3) Experts (2) Important (2) Infection (2) About (1) Analysis (1) Causes (1) Eliminate (1) stroke (1)

AD

Friday, June 22, 2012

Fitness playlists flow to the beats per minutes

AppId is over the quota
AppId is over the quota

NEW YORK (Reuters) - When fitness instructor Shirley Archer plays Annie Lennox's song "17 Again" for her indoor cycling class, she urges students to connect with the vitality of their inner 17-year-old legs.

When she teaches yoga she rolls out the harp solos.

Experts say exercising to the proper music can boost your mood, kick your workout up a notch and channel the energy of a younger you.

"Fitness playlists are extremely important," said Archer, who is also a spokeswoman for the American Council on Exercise. "A number of studies show that music can impact mood, emotions, energy levels, even breathing and heart rates."

Archer, author of 12 books on fitness and wellness, including "Fitness 9 to 5," said the research comes from music therapy, sports, surgical recovery and gait training studies for people with neurodegenerative issues.

"Music is powerful because it stimulates different neural pathways in the brain and taps powerfully into our emotions and our memories," said Archer, who lives in Singer Island, Florida, and Zurich, Switzerland.

Not only can music help people power through workouts, she said, it can distract them from boredom, fatigue and discomfort.

"Think about how people who are middle-aged or older find their dancing feet when they hear tunes that were popular when they were in their teens or early 20s," she said.

Also a powerful tool for relaxation, music can help to slow and calm heart and breathing rates, reduce stress and evoke feelings of peace and balance.

A good fitness playlist will match the workout objectives, Archer said. An aerobic workout should start out with uplifting music at a tempo of about 130 BPM (beats per minute) and build to around 150 BPM.

"Studies show that this is a moderate aerobic pace for most people," she said. "Think of the tunes 'Stayin' Alive,' '9 to 5' or Justin Timberlake's 'Rock Your Body.'"

Toward the end of the workout, she said, the pace should slow again.

MAXIMUM BENEFIT

Deekron Krikorian, known professionally as Deekron the Fitness DJ, designs and produces fitness playlists for specific workouts based heavily on BPM.

"The typical exerciser listens to music to kill boredom, reduce the perception of pain," said Krikorian, whose hour-long podcasts, called Motion Traxx, are on iTunes. "The main purpose is to motivate you, but unless you fit the pacing to your workout, you're not getting the maximum benefit."

That's where Krikorian comes in.

"Every episode is set at a different BPM. We tweak it. We're able to manipulate it. Most people don't have the tools to do that on their own."

For most people, a power walk would involve 125-135 musical beats per minute, said Krikorian, who started out making fitness CDs for instructors and consumers. He said 135-145 BPM works for an elliptical workout or an easy jog. Above 150 BPM puts you in the running zone.

Some Motion Traxx podcasts include trainers to coach you through the workout.

The rise of the iPod and iPhone have allowed playlists to become so specific, he said.

"They let us bring music with us," he said. "Walkmans helped, but the iPod and iPhone have taken things to another level."

Josh Adler, who teaches spinning at the New York Health & Racquet Club, a chain of fitness centers in New York City and Long Island, creates his own playlist.

Pop divas Rihanna, Lady Gaga and Madonna are among his staples, along with music from the 1980s and 1990s he discovered on the dance floor.

"I want people to recognize a couple of songs," he said. "So the time goes by more quickly."

He said remixes are often ideally suited to the high-intensity interval training of his class.

"The first minute is a steady beat, the lyrical hook. Then the music intensifies on the chorus," he said. "The intervals last 30 to 60 seconds, which is perfectly matched to what your body needs to do."

Krikorian keeps his podcasts fresh by changing them at least once a month.

"Music can play a really big role in fitness if used the right way," he said. "It's a new twist on an old song that gets them really excited."

(Editing by Patricia Reaney; editing by John Wallace)

Is ur #MD 2 square? Some use e-tech with patients

AppId is over the quota
AppId is over the quota

CHICAGO (AP) — Is your doctor a technophobe? Increasingly, the answer may be no. There's a stereotype that says doctors shun technology that might threaten patients' privacy and their own pocketbooks. But a new breed of physicians is texting health messages to patients, tracking disease trends on Twitter, identifying medical problems on Facebook pages and communicating with patients through email.

So far, those numbers are small. Many doctors still cling to pen and paper, and are most comfortable using e-technology to communicate with each other — not with patients. But from the nation's top public health agency, to medical clinics in the heartland, some physicians realize patients want more than a 15-minute office visit and callback at the end of the day.

Far from Silicon Valley and East Coast high-tech hubs, Kansas City pediatrician Natasha Burgert offers child-rearing tips on her blog, Facebook and Twitter pages, and answers patients' questions by email and text messages.

"These tools are embedded in my work day," Burgert said. "This is something I do in between checkups. It's much easier for me to shoot you an email and show you a blog post than it is to phone you back. That's what old-school physicians are going to be doing, spending an hour at the end of the day" returning patients' phone calls, she said.

She recently received a typical email — from a mother wondering how to wean her 2-year-old from a pacifier. With a few thumb clicks, Burgert sent the mom a link to a blog post offering tips on that same topic.

Sarah Hartley, whose two young daughters are Burgert's patients, loves having e-access to the doctor and says even emails late in the evening typically get a quick response.

"It's so useful," Hartley said. "Sometimes parents get concerned about a lot of things that maybe aren't necessarily big deals" and getting off-hours reassurance is comforting, she said.

Burgert, 36, doesn't charge for virtual communication, although some doctors do. She says it enhances but doesn't replace office visits or other personal contact with patients.

Colleagues "look at me and kind of shake their heads when I tell them what I do. They don't have an understanding of the tools," Burgert said. "For the next generation that's coming behind me, I think this will be much more common."

Dr. Steven Nissen is from an older generation, but has started to dabble in e-technology. A cardiologist at the Cleveland Clinic, Nissen is in his 60s and says he's hardly a member of "the Twitterati." But with help from clinic staffers, he recently led a live Twitter chat about things like heart failure and cholesterol problems, and found the process "in some ways maybe a little exhilarating."

"This was an opportunity to use a different communication channel to find an audience to talk about heart health," Nissen said.

"The downside is that we dumb it down," he said. "It's very challenging for physicians, primarily because the messages that we have are not conducive to 14 characters. If you ask me a question, you're likely to get a five-minute answer."

But with so many young people facing obesity, which can contribute to heart problems, Nissen said Twitter can be an effective way to reach an important audience, and he plans to use it more.

"If it gets us through to the people who need to hear the message, that's great," Nissen said.

The American Medical Association acknowledges benefits in using social media, but also warns doctors to protect patient privacy and "maintain appropriate boundaries" with patients.

In a publicized case that makes doctors shudder, a state disciplinary board last year reprimanded Rhode Island emergency medicine physician Alexandra Thran for "unprofessional conduct" and fined her $500 after she made comments on her Facebook page about a patient's injury. Even though she didn't name the patient, others who read the post figured out the identity. Thran did not respond to requests for comment.

Dr. Raoul Wolf, a pediatrics professor at the University of Chicago, doesn't use social media sites personally or professionally and worries about the permanence of online communication.

"With anything on the Internet, it's there forever. There's no calling it back," Wolf said. "Ask any politician."

Hard numbers are scarce on exactly how many of the nation's nearly 1 million doctors use virtual communication for patient care, but anecdotal evidence suggests the numbers are rising.

A survey last summer of 501 randomly selected doctors found that more than 20 percent engaged in emails with patients over secure networks, and similar numbers had websites allowing patients to schedule visits or download test results. Only 6 percent communicated with patients through social media; that translates to about 60,000 doctors nationwide.

Doctors' use of social media and virtual communication for patient care is expected to increase under the Accountable Care Act, which encourages electronic health records and the "electronic exchange" of health information.

A study published online in March found that 60 percent of state public health departments use Twitter or another social media site, mostly to distribute information rather than interact with patients.

The federal Centers for Disease Control and Prevention spreads its public health messages by Facebook, Twitter, YouTube and text-messaging. It offers a free service featuring 12 texts a month, including automated tips for healthy eating and other obesity prevention advice. The CDC has almost 2 million followers on its social media sites, said Amy Burnett Heldman, the agency's social media leader.

The agency's leader, Dr. Tom Frieden, has done six live Twitter chats since December, interacting in real time online with the public.

"There's a way 4 everyone 2 work out, u just have 2 find your way around what obstacles may b in your path," Frieden tweeted May 21 in his most recent Twitter chat, about obesity prevention.

CDC scientists also monitor social media sites including Twitter for disease surveillance. One instance involved Indiana measles cases that first showed up a few days before the February Super Bowl. CDC officials monitored Twitter and Facebook posts about rashes and emergency room visits to determine if the outbreak was a widespread threat — it wasn't. Another involved an outbreak of suspected Legionnaires disease among people who attended a 2011 event at the Playboy Mansion in Los Angeles. Word of that illness surfaced when a German businessman who attended posted about his flu-like symptoms on Facebook, and CDC used social media sites to help locate the illness source — a whirlpool spa.

Heldman says using social media makes sense for an agency whose goal is to improve Americans' health.

"You're meeting people where they are, where they share information with others, where they go to get information," she said. "That's allowing CDC to have an even greater reach."

In other examples:

—Public health officials in Santa Clara County, Calif., have posted YouTube videos warning kids about excess sugar in sodas and juice boxes. And health agencies in San Francisco and Washington, D.C. have used text messages to send safe-sex advice to teens, including what to do when a condom breaks.

—Dr. Jennifer Dyer quit her pediatrician job in Columbus, Ohio, last year to start a social media-based patient education company after running a small study that showed text messages helped her teenage patients better manage their diabetes. She's creating smartphone apps that will do the same.

—The famed Mayo Clinic holds "Tweet camps" to train its doctors how to use Twitter appropriately, said Lee Aase, director of Mayo's Center for Social Media in Rochester, Minn.

Says Aase, "If we can trust doctors with sharp instruments and narcotics, we can trust them with Twitter and Facebook."

GSK extends its $2.6 billion offer for Human Genome

AppId is over the quota
AppId is over the quota

LONDON (Reuters) - GlaxoSmithKline has extended its $2.6 billion offer to buy long-time partner Human Genome Sciences until the end of June as it battles the U.S. biotech company's reluctant management.

The price remains unchanged at $13 a share under the longer tender, which will now expire at 5 p.m. EDT (2100 GMT) New York time on June 29, Britain's biggest drugmaker said on Friday.

The initial tender period ran out at midnight on June 7, by when GSK had secured less than 1 percent of Human Genome shares, which are trading at a premium to its offer.

People familiar with the situation had previously told Reuters that GSK was set to extend its tender offer - a direct appeal to Human Genome shareholders over the heads of management - as it begins a process to replace the entire Human Genome board with its own nominees.

The British company has already started reaching out to executives in the drug industry as well as finance and governance experts who could be nominated as independent directors of the 12-member board.

Sources said on May 30 that GSK intended to seek approval from Human Genome shareholders to replace the board under a "consent solicitation" process, which could come in the next few weeks. No details on the process were given on Friday.

Human Genome once again rejected GSK's bid as inadequate. It has launched an auction process, inviting GSK to participate, while at the same time adopting a "poison pill" shareholder rights plan in a bid to thwart the hostile takeover attempt.

The U.S. firm has had contacts with other companies and said on Friday that the process "continues to be active and fully underway". But no counterbidder to GSK has emerged and bankers say GSK has an advantage over rivals because of its partnerships around key drugs.

The two companies together sell Benlysta, a new drug for the autoimmune condition lupus, and they also collaborate on two other experimental drugs for diabetes and heart disease that could become significant sellers. GSK and Human Genome share rights to Benlysta, while GSK owns the majority of the commercial upside to the other products.

Buying Human Genome would give GSK full rights to these partnered drugs, underscoring the appetite among big drugmakers for biotech products to refill their medicine chests.

But GSK may have more work to do in persuading investors that its $13-per-share bid is good enough and shares in Human Genome traded 2 percent higher at $13.50 by 1430 GMT.

That indicates investors still expect a higher price, although the stock has fallen back from a high of more than $15 hit in April, soon after the unsolicited offer was made public.

(Editing by Kate Kelland and Hans-Juergen Peters)

Georgia woman with flesh-eating disease in "critical" condition

AppId is over the quota
AppId is over the quota

(Reuters) - A Georgia woman fighting a flesh-eating bacterial infection was in critical condition at Augusta Hospital on Saturday, a hospital spokeswoman said.

The spokeswoman said she could not comment on whether Aimee Copeland had undergone surgery to remove her hands and right foot, amputations that Copeland's father had said were pending on Friday. Surgeons had amputated the 24-year-old's left leg at the hip.

"All I can say is Aimee is still in critical condition," hospital spokeswoman Barclay Bishop said.

Prayers and messages of support have poured in for Copeland on a Facebook page where her father, Andy Copeland, has chronicled her struggle.

There were no updates on the site on Saturday. The Atlanta Journal Constitution newspaper said the family had been overwhelmed by public interest and had asked for privacy.

Copeland suffered a huge gash in her leg in a zip-line accident and fell into the Little Tallapoosa River near Carrollton, Georgia, on May 1. She developed necrotizing fasciitis, a bacterial infection that destroys soft tissue.

Necrotizing or "flesh-eating" soft-tissue infections are a broad category of infections with many causes, although Group A Streptococcus is the most common culprit. Doctors blamed Copeland's infection on the Aeromonos hydrophila bacteria, which are found in fresh or brackish water and may have entered the wound when she fell into the river.

With media attention focused on Copeland's struggle, additional cases of necrotizing fasciitis have been reported in Georgia and South Carolina. Health experts say the disease is not communicable.

A 1996 report from the U.S. Centers for Disease Control and Prevention estimated there were 500 to 1,500 cases of necrotizing fasciitis annually in the United States, with about 20 percent of them fatal. The National Necrotizing Fasciitis Foundation says on its website that the case number estimate is probably low.

(Reporting By Jane Sutton; Editing by Greg McCune and Jackie Frank)

Health Tip: Help Prevent Heart Disease

AppId is over the quota
AppId is over the quota

(HealthDay News) -- You can't control all risk factors for heart disease, but living a healthy lifestyle and taking medication prescribed by your doctor can help prevent many of its dangerous risk factors.

The Womenshealth.gov website suggests these steps to help reduce your risk of heart disease:

Maintain healthy cholesterol and blood pressure.Quit or avoid smoking and drinking too much alcohol.Take steps to control diabetes.Maintain a healthy body weight.Get plenty of regular exercise and adhere to a regular sleep schedule.Control conditions such as sleep apnea and metabolic syndrome.

Copyright c 2012?HealthDay. All rights reserved.

Water safety campaign breathes life into Jones

AppId is over the quota
AppId is over the quota

LONDON (Reuters) - Cullen Jones was five when he almost drowned but rather than live in fear of water the American jumped back in with both feet, overcoming his fears to become an Olympic swimming gold medalist and drive a campaign to slash the drowning rate in the United States.

The 28-year-old, who won relay gold in Beijing and hopes to earn an individual berth at the London Games, was put straight into swimming lessons by his mother after the water park accident.

Jones now juggles his training with a campaign to lower the disproportionately high drowning rate among African-Americans and stressed the importance of teaching children how to swim.

"In 2008 the drowning rate for African-Americans in the United States was three times more likely than any other rate," Jones told Reuters via telephone after one of his training sessions at the gym.

A national research study by the USA Swimming Foundation and the University of Memphis showed 70 percent of African-American and 60 percent of Hispanic/Latino children could not swim.

Recent statistics from the Centers for Disease Control and Prevention also showed more than one in five fatal drowning victims are children younger than 14.

"Swimming is a life skill," added Jones.

"The biggest problem in the United States is people see it only as an activity, as something fun you do on vacation. But kids are going into the water and drowning. There's a simple way to stop this."

Jones said he owed a great deal to his parents for forcing him to confront his fears at an early age.

"My dad and I talked my mum into letting me on this ride and I ended up being flipped upside down, almost drowning and needing full resuscitation. My mum got me into swimming lessons within a week," he recalled.

"I see tragedy bringing on triumph every day working with Make a Splash. But so many of their parents don't do what my parents did.

"So many tell their kids to stay away from the water."

Jones said his work at the Make a Splash programme since 2008 had made him a better swimmer.

"I'm able to swim at speeds I wasn't four years ago. I'm in better shape now and I've learned a lot. I knew I wanted to help get kids water-safe, but I didn't know how much of an impact that would have on me," he added.

"Seeing their faces light up, those are the faces I see when I'm tired or can't get through the wall."

INDIVIDUAL FOCUS

Another factor driving Jones forward to the London Games is the hurt of missing out on individual competition in Beijing after he delivered a performance that was far from his best in the 50-metres freestyle at the 2008 Olympic trials.

"That's been the one thing burning in the back of my head for the last four years. I messed up at the trials and didn't swim my own race. That hurt," said Jones.

"I love swimming relays but I want to swim an individual. That's my focal point."

Jones will have the chance to claim an individual berth at the June 25-July 2 national trials, which he hopes will be the first of two major peaks in his 2012 form.

"Last year I went to the worlds, then I came back and went to the nationals, which was to replicate what it would feel like to go from one meet at my peak straight to another.

"In 2008 I was able to hit a double peak. I think I'm still going to be able to do that, we've been training to do that. My yardage this year has been more than the past three years.

"Hopefully the Olympics will be the stronger peak."

Jones credits 14-times gold medalist Michael Phelps and best friend Ryan Lochte for providing support as well as a rivalry that keeps them constantly striving to beat each other and set new boundaries.

"Ryan and I have been roommates since 2006 when I first made the international team, we've been friends ever since.

"Last year I had to race one of my team mates to make the worlds team and he was definitely in my corner, along with Michael of course. The three of us are pretty tight."

The laughter will be pushed aside when the country's best swimmers convene for the fiercely competitive national trials.

"Because we're only together for that month, being known as Team USA and walking around like that you just get fired up," he said. "Knowing that for that month you're training with the best in your country, you can't not catch that Olympic feeling."

(Edited by Peter Rutherford)

Thursday, June 21, 2012

To protect from cancer cell death 2 approaches

Summary:

There are different security applications without creating a most cancers, and avoid getting under the cell management pressure and to protect them from split two. Until now, these safety scientists believed, wheeled technology independently from each other. Cancer is a scary term. Passed from cancer, most people away very got sick and tired of someone we know. In most cases, affect cancer aged.

The main idea:

Many disease-related groups and all cells need actually cancer. Cell is including the human body, living thing, a very small unit. Measurement of cells in each person's body is not possible.

Recurring cancer cells most of what happens. Usually develop the cell splits, and know the increases stop. Also take the time to die. Split opposed the regular cells, cancer cells only increased control when they are supposed not to die is.

Cancer cells are usually group together the heap of forms of cancer or. You can eliminate the growth of normal cells around the tumor growth and makes masses of malignant tumor cells of malignant melanoma, damage healthy cells in the body. People very sick can be.

The cause of the cancer:

Development eventually, recalcitrant, most cancer is the result of the tissue doesn't die. Regular organizational body, run AutoArchive path loss of growth, Division, and life. Called and apoptosis of cell loss of life of the design, this process of seizure if starts melanoma malignant tumors to form. Whereas a regular organization, malignant tumors of melanoma have caused loss of life program increase instead, split. This happens mass irregular organization, out of control development.

Cancer treatment:

Most cancer treatment is determined by the stage of the additions to the position of a type of malignant tumor of malignant melanoma, melanoma, how much it spread malignancy, age, health, and personal. Malignant tumor of malignant melanoma, one strategy no patients receive modern and various treatment often. The treatment usually following categories classified: surgery or x-ray, light therapy, immunotherapy, hormone therapy, gene therapy.

May change apoptosis fairly malignant melanoma, malignant tumor tissue apoptosis route is actually probably capacity traditional treatment is often most cancer organizations to view the mediation level by non-effective capacity. Therefore, the main purpose of study of malignant melanoma, malignant tumors is to succeed this route to reactivate apoptosis, use system defects in the development of new strategies for cancer cell growth and migration hand.

Autophagy is broken, unwanted proteins and organ clearance mobile phone degradation pathway. Recycling the elements in these cells also helps to keep constancy and practicality during metabolic stress time as a power source. In the matter of apoptosis in tumor tissue can Autophagy extended success. Paradoxically, is associated with tumor of Autophagy issue improvement and behind this procedure is not established. Shows the description of safety features to limit the swelling and the latest evidence of Autophagy tumor necrosis and reduce genome damage in reaction to the pressure of the tumor tissue metabolism.

Forgiveness is a great word to anyone with cancer the most. In other words, body is missing from all the symptoms most cancers. Medical treatment, chemotherapy or x-ray, treatment after doctors [would evaluate whether cancer is still in. In the absence of symptoms of cancer, remission is a child.

When you go to the Medical Center in cancer therapy for most of all children is the purpose of forgiveness. From phototherapy add this awhile back, you must to keep cancer organizations shows.

Conclusion:

Overall the techniques described above, recognition of target molecules play an important role in most cancer drug resistance means a challenge to most cancer analysis, self-defeating. Now standard concept of quiet apoptosis activation in parallel, can be a valuable treatment of cancer tissue modulation of Autophagy's most sensitive to modern concepts. In need of answers to some United Nations concerns further recognizes the interconnection between the steps work yet.

Germany to oppose easing of GM trace rules: report

AppId is over the quota
AppId is over the quota

HAMBURG (Reuters) - Germany will oppose any European Union move to allow traces of unapproved genetically-modified (GM) organisms in food in a similar way to the tolerance level permitted by the EU in animal feed, a German newspaper said on Monday.

In the summer of 2011, the EU adopted new rules allowing traces of unapproved GM material in animal feed imports, in a bid to prevent disruption feed grain imports as GM crops are introduced more quickly in other regions than the EU approves new types.

But German Farming and Consumer Protection Minister Ilse Aigner would oppose any move to end the zero-tolerance rule for unapproved GM content in imports of human food, the daily newspaper Sueddeutsche Zeitung reported.

Aigner believes changing the zero-tolerance rule for food imports would damage the rights of consumers to buy GM-free food if they wish and would also reduce transparency of food labeling, the report said.

EU policy on GM crops has long been politically fraught, with a majority of European consumers opposed to modified foods, but with GM crops now making up a large proportion of harvests in North and South America.

New GM strains are approved most years in these regions but such crops cannot be imported by the EU even in tiny traces until given the green light by the bloc's approvals process.

Food industry lobbies in Germany and other countries are pressing for a modest level of non-approved GMs to be permitted in food to prevent disruption to trade, the report said.

In 2009, U.S. soybean shipments to Europe were blocked after small traces of unapproved GM material were found in some cargoes. This led to the EU decision to permit a 0.1 percent level of unapproved GMs in animal feeds but not human food.

But even such small amounts are opposed by some environmentalists who argue that the effect of consuming GM crops is unknown.

(Reporting by Michael Hogan; editing by Jason Neely)

The most universally valuable health supplements

Although the most effective way to provide with the frame for vitamins and minerals required for healthy run is through such a well-balanced diet plan and also skinny, much of the population enjoy Maggi supplements to help the healthy diet. In a society increasingly rely on foods and crashes dinner soon, it may be daunting to be able to meet simple needs the best threads of sound.

Groups of people who May well require other vitamins and minerals than are ordinary process source contain women await health, caring mother, hypersensitive patients or maybe food intolerances, residents and strict vegetarians. General health tea that ares ideal for being able to an individual is founded on those individuals and temperature; now there will be absolutely no universal tea to be believed in order to meet all uses of any people.

Several artifacts that enhance your lifestyle to a customer regardless of age group and health history. Caffeine is often recognized as a stimulant, can speed up a slow metabolism and energy nourishment. A determination regarding caffeine should but not 400 mg a day, in every other case, ares shakiness going to be older. Primary biological tea antioxidant, EGCG, hedge against coronary heart conditions and cancer. In response, worked long on caffeine increases your body rhythm for you at 4%. For further metabolism via the control handle of insulin, chromium is highly efficient in relation to someone with diabetes or diabetic situations or even insulin resistance.

Another useful tea may be of 5-HTP, or even Simplicfolia, where drug Griffonia is a kind of amino acids that is efficiently become serotonin. Not only complete appetite to curb aid 5-HTP, freeing of serves as a standard antidepressant. Conjugated linoleic acid (CLA) need control calories and maximize muscle, together. This is a fatty acid normally employed in meat and dairy products. Contrast compounds that may help you better understand and take care of hunger may be l-dopa, which usually will immediately take in once dopamine. Lack of dopamine level are connected to related actions of overeating under search, based on your daily average to evaluate cultural natural solutions at the school in Mississippi. L-dopa results in your human growth hormone that triggers the development of muscle mass and is fat. They are the best health supplements generally acceptable, although an employee to any local store nutrition can help you assess your individual needs.
natural vitamin
natural vitamin

natural vitamin

Use and distribution of this article is subject to our Publisher guidelines
whereby the original author and copyright information must be included.

Health Tip: Preparing for Colonoscopy

AppId is over the quota
AppId is over the quota

(HealthDay News) -- A colonoscopy allows doctors to inspect the colon to detect inflammation, sores or unusual growths.

Preparing for the procedure involves completely emptying the colon to give doctors an unobstructed view. The National Digestive Diseases Information Clearinghouse offers these suggestions to help you prepare for colonoscopy:

Follow your doctor's orders for dietary restrictions, which typically include no solid foods for one to three days before the procedure.Adhere to a clear liquid diet, specifically avoiding liquids that contain purple or red dye.The night before the procedure, your doctor may ask you to take a laxative and/or enema to clear your bowels.Tell your doctor about any medications, supplements or herbs that you are taking.Make arrangements for someone to drive you home after the colonoscopy.

Copyright c 2012?HealthDay. All rights reserved.

Females, Young Athletes Take Longer to Get Over Concussions

AppId is over the quota
AppId is over the quota

FRIDAY, May 18 (HealthDay News) -- Female athletes take longer to recover from concussions, a new study says.

Young athletes also have longer recovery times. The findings show that doctors and athletic trainers need to take gender and age into account when treating patients with concussions, said researchers from Michigan State University.

The researchers studied data from nearly 300 athletes in the United States who suffered concussions, all of whom had completed a baseline test prior to their head injury and took three different post-concussion tests.

Compared to males, females performed worse on post-concussion visual memory tests and reported more concussion symptoms. The researchers also found that high school athletes did worse than college athletes on verbal and visual memory tests. Some of the high school athletes still showed mental impairment up to two weeks after the injury.

"While previous research suggests younger athletes and females may take longer to recover from a concussion, little was known about the interactive effects of age and sex on symptoms, cognitive testing and postural stability," study leader Tracey Covassin, a certified athletic trainer at Michigan State, said in a university news release. "This study confirms that age and sex have an impact on recovery, and future research should focus on developing treatments tailored to those differences."

The study appeared May 8 in the American Journal of Sports Medicine.

"We need to raise awareness that female athletes do get concussions," she said. "Too often, when we speak with parents and coaches, they overlook the fact that in comparable sports, females are concussed more than males."

Covassin also said the study points out a potential danger to younger athletes who resume play before they're fully recovered from a concussion.

"Younger athletes appear more at risk for second-impact syndrome, where a second concussion can come with more severe symptoms," she said. "While it is rare, there is a serious risk for brain damage, and the risk is heightened when athletes are coming back before they heal."

More information

The American Academy of Family Physicians has more about concussions.

Copyright c 2012?HealthDay. All rights reserved.

Treat drug abuse as public health issue, US czar says

AppId is over the quota
AppId is over the quota

President Barack Obama's top adviser on drug policy called Monday for greater emphasis on treating drug abuse as a public health problem in the United States rather than as a crime.

In a speech at the Betty Ford Center in Palms Springs, California, Gil Kerlikowske blamed US laws punishing drug consumption for making it harder for drug addicts to get treatment.

"Our nation's drug problem should be treated as a public health issue, not just a criminal justice issue," he said.

"Too many laws and regulations that were established for the purpose of punishing or deterring drug use make no distinction between the person who continues to use drugs and the person who is on the pathway to recovery," he said.

Kerlikowske's Office of National Drug Control Policy in April unveiled a new counter-drug strategy that calls for more than 100 changes in US law and counter-drug programs.

His office estimates that 23.5 million Americans were in treatment for alcohol or narcotics addiction in March.

It also reported that cocaine consumption has fallen by 40 percent since 2006, and drug consumption generally has declined by a third since 1979 in the United States.

But marijuana use among the young remains stable, and authorities are alarmed by the rise of synthetic drugs with devastating effects.

Immunology strengthens the fight against Colon Cancer Stage 4

Immunotherapy is undoubtedly a new medical strategy that evokes the human immune system to eradicate the disease. To summarize, in a span of 30 years, focusing the research conducted by both teams of doctors and scientists has shown that this approach is clinically successful for a wide range of diseases. Advances in adoptive immunotherapy, which focuses on expanding and infusion of specific disease-fighting white blood cells in patients, fast have followed this scientific arena its peak in terms of being an effective treatment for viral diseases, colon cancer, and surprisingly even stage 4 cancer types.

We can suppose, taking into consideration the reliable results and continuous progress, the importance of immunotherapy to grow exponentially-especially as it applies to late stage colon and other Stage 4 cancer. Currently, colon cancer stage 4 targets with little more than chemo and radiation, so the statistics are grim ... Renowned care providers do not dare report data of survival beyond the first couple of years as it is disappointing, with marginal promise.

New immunotherapy treatments, however, are inspiring as they provide an essential part of the puzzle-treatment with better overall results collaborated and quality of life for patients.

Envita leads the field in stage 4 Colon Cancer

A string of results published are shown the effects of adoptive immuno therapy in cancer patients. Dedicated medical team of Envita has evaluated the most reliable studies said and given the strengths and weaknesses of each. Their Immaculate research requires a protocol that incorporates only the most effective procedures for the extension and application of cells as a powerful immunotherapy. Our protocols are based on the latest published literature in the arena, by many hospitals and universities most prestigious both nationally and globally. Predictably, our treatment has been specially formulated specifically to treat colon cancer and immune systems of cancer patients in 4 phases.

Of Envita Colon Cancer 4 dual phase and immunotherapy of cancer 4th stage

Natural Envita Medical Center established in Mexico is using NK and CTL cells in real-time as immunotherapy for treatment of cancer and stage 4 colon cancer. Immune therapy of proprietary vaccine Envita appropriately is labelled AAIT\R (for immune system therapy autologous foster), and there are 4 main types of cells involved-the most significant being natural killer cells and T cells. The following are the types of cells that make up the treatment of Envita:

= > ‧ Natural killer cells
= > ‧ Natural killer t cells
‧ Cytokine Induced > = killer cells
= ‧ Cytotoxic T lymphocytes >

The being was created with the expansion of a patient's own immune cells in antitumor mega amounts. These cells are then analyzed for activation indicators and highlighted for their ability to destroy the colon cancer and other cells in the laboratory under controlled conditions, and then re-infused into the patient.

AAIT\R immunology available for Colon cancer and Stage 4 cancer patients to Mexico Envita

Natural Envita Medical Center is currently using T lymphocytes, NK and NKT as support for immunotherapy of cancer patients. Proprietary Envita vaccine stage 4 colon cancer is recorded as AAIT\R-one who increases a patient's own cancer cells of the immune system in the billions in a span of several weeks. These cells are evaluated for indicators, analysed for their ability to neutralize tumor cells stage 4 colon cancer in the lab and then eventually re-infused into the patient. Heralded by scientific research and clinical results of AAIT\R immunotherapy Enivta presents a valuable option for cancer patients who are acutely dedicated to conquering colon cancer stage 4 and others, while a intact immune system balance. Envita administers only top-level combinations of conventional cancer treatment and alternative accentuated by advanced cancer treatment natural help patients secure better health and improve the overall quality of life.

Understanding Stage 4 cancer is vital for those patients seeking remission of cancer at any stage. Recognizing necessary approaches, you will improve your chances of remission, the quality and length of life. Patients involved with the most comprehensive treatment plans always respond better to treatment. Let Envita better tailor prostate cancer Stage 4 treatment plan in place for you.

Use and distribution of this article is subject to our Publisher guidelines
whereby the original author and copyright information must be included.

Health Highlights: May 23, 2012

AppId is over the quota
AppId is over the quota

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:

Radiation Exceeded Cancer-Causing Levels in Some Areas Around Fukushima Nuclear Plant: WHO

Several areas near the Fukushima nuclear plant in Japan had radiation above cancer-causing levels, but most of the nation did not, according to a World Health Organization report released Wednesday.

The first global report about radiation exposure from last year's meltdowns at the nuclear plant said increases in radiation were below cancer-causing levels in nearly all of Japan, the Associated Press reported.

Neighboring countries had radiation levels similar to normal background radiation, while the rest of the world had some minor radiation exposure through food.

Previously, the U.N.'s International Atomic Energy Agency confirmed that radiation levels in some Japanese vegetables and milk were much higher than Japan allows for consumption, the AP reported.

-----

Bagged Salads Recall Expanded

More types of River Ranch Fresh Foods bagged salads are being recalled after routine sampling detected contamination with Listeria monocytogenes bacteria.

The initial recall by the Salinas, Calif.-based growing included lettuce shipped to California and Colorado. The expanded recall includes bagged salads that were shipped nationwide and sold under the names River Ranch, Farm Stand, Hy-Vee, Marketside, Shurfresh, The Farmer's Market, Cross Valley, Fresh n Easy, Promark and Sysco, reported CBS News and the Associated Press.

No illnesses have been reported, according to the company.

The recalled salad bags have "best by" dates between May 12 and May 29, or Julian dates of 118 and 125, CBS/AP reported.

For more information, consumers can call River Ranch 24 hours a day at 1-800-762-7708.

-----

Chicken Jerky Treats Have Sickened 900 Dogs

The latest tally of complaints from worried dog owners and veterinarians shows that the U.S. Food and Drug Administration has received 900 reports of canine illness and death associated with chicken jerky strips, treats and nuggets since November.

Complaints include cases of problems ranging from vomiting and diarrhea to kidney failure and other serious ailments after dogs consumed the Chinese-made treats, msnbc.com reported.

Waggin' Train and Canyon Creek Ranch brands produced by Nestle Purina PetCare Co., and Milo's Kitchen Home-style Dog Treats, produced by the Del Monte Corp, are among the brands of chicken jerky treats cited by pet owners and veterinarians in their complaints of harm filed with the FDA.

Both companies have said their chicken jerky treats are sound and that any pet illnesses are unrelated to the products, msnbc.com reported.

-----

Auction of Vial With Reagan's Blood Stirs Controversy

A vial that allegedly contains blood residue from former U.S. President Ronald Reagan is being auctioned off by a Channel Islands auction house.

The PFCAuctions house said the vial was used by the laboratory that tested Reagan's blood when he was hospitalized after a 1981 assassination attempt in Washington, D.C., the Associated Press reported.

Bidding for the vial passed the $11,000 mark Tuesday. The auction ends Thursday.

The auction was condemned by John Heubusch, executive director of the Ronald Reagan Presidential Foundation in California, the AP reported.

"If indeed this story is true, it's a craven act and we will use every legal means to stop its sale or purchase," Heubusch said in a statement. "We've spoken to GW (George Washington) Hospital and are assured an investigation as to how something like this could possibly happen is underway.

"Any individual, including a president of the United States, should feel confident that once they enter into the care of a medical system their privacy and rights are held inviolable," he said.

-----

Copyright c 2012?HealthDay. All rights reserved.

Noisy Wards Could Threaten Hospital Patients' Health

AppId is over the quota
AppId is over the quota

MONDAY, June 11 (HealthDay News) -- A new study suggests that sleep doesn't come easy for many hospitalized patients, with everything from ice machines to traffic to hallway talkers keeping them awake.

The finding, from a small study of 12 healthy people exposed to typical hospital noises, should sound an alarm about the effects of noise on patients' health.

"Everyone knows that sound disrupts sleep, but in a hospital setting this is a really big problem," said study lead author Orfeu Buxton, an assistant professor at Harvard Medical School, as well as an associate neuroscientist in the division of sleep medicine in the department of medicine at Brigham and Women's Hospital in Boston.

"There are noises that are happening all around patients . . . all the time, each of which, one after the other, is disrupting their sleep," he said. "IV pumps, alarms, phones, the voices of the staff on duty. And exposure to all of this -- even at the level of a whisper -- can actually accelerate a patient's heart rate by four or 10 beats a minute."

All of that can trouble sleep "and cause the kind of enormous patient disruption that can really compromise a patient's recovery process," Buxton said.

The findings are published online June 12 and in the June 19 print issue of the Annals of Internal Medicine.

According to the researchers, hospital patients queried in recent surveys often cited noise as a major factor negatively affecting their quality of care.

But what types of noise matter most? To find out, Buxton's team had a dozen healthy, young men and women spend three nights in a sleep laboratory.

After one night of normal sleep without exposure to noise recordings, all of the participants were then asked to try to sleep while being exposed to recordings of typical hospital sounds. "Internal" noise included gurneys moving down hallways, ice machines, staff conversations, IV drip alarms and phone calls. "External" noises included street traffic and helicopter passings.

Throughout, the participants' sleep patterns and heart rates were monitored. Predictably, as noise levels went up so did sleep disruption.

Not all noise was equally disturbing, however. The beeps and blips of medical equipment electronics, for example, were found to be more disruptive than people talking or the noise of traffic.

Nevertheless, even a momentary noise disturbance was associated with a bump in heart rate, the team found. This was true while participants were in deep sleep, but it was most problematic when they were in the lightest stage of sleep (so-called REM sleep).

The findings were sadly familiar to one expert.

"Certainly, sleep deprivation and disruption is very common in the ICU [intensive care unit], where I practice most of my medicine," said Dr. Gulshan Sharma, director of the Medical Intensive Care Unit at the University of Texas Medical Branch at Galveston. He agreed with the study's list of noise-makers, and said that "all of this contributes to sleep fragmentation and a lack of deep sleep [for patients]."

Buxton's team noted that the typical hospitalized patient is usually older than those in the study group, and therefore likely to be subject to other non-noise issues that can also affect sleep quality. The issue is real and serious, given that sleep disturbance can prompt or exacerbate a number of serious health issues, including a rise in blood pressure and stress hormones or a dip in immune function and mental health.

Lowering the noise level on wards "would decrease patient stays and improve healing, and perhaps even reduce readmission rates," Buxton said, and hospitals do have means of doing so.

"Checking vital signs and delivering medicine, for example, can be delivered at the same time to reduce noise disturbance for patients," he said. "Night workers can be instructed not to speak at full day volume during their shift, because patients are sleeping. Alarms can be going to a central monitoring place, because the intention is, in the first place, to direct them to the staff and not at the patients. And there's no reason that the phone in the patient's room should go off at 2 in the morning. That call can definitely wait. Basically, all things we take for granted at home should be the standard in a hospital setting as well," Buxton explained.

Sharma agreed, especially with regard to centralizing various medical alarms away from the patient. "Using better technology, perhaps that is possible," he said. "That's probably where I think the field will be going."

"If the hospital is a place to heal then it needs to be a quieter environment," Buxton added. "We're talking about non-trauma places in a hospital where it would be possible, with some behavior changes by staff as well as in the layout and design of the space, to make the overall environment quieter. It's certainly a fixable situation."

More information

There's more on sleep's links to health at Harvard University.

Copyright c 2012?HealthDay. All rights reserved.

No Cancer Risk From Long-Acting Insulin: Studies

AppId is over the quota
AppId is over the quota

MONDAY, June 11 (HealthDay News) -- Three studies should squelch fears that taking a form of insulin called insulin glargine (Lantus) increases the risk of cancer, researchers say.

Prior research had suggested an increase in cancer risk with Lantus, an injectable drug used to treat diabetes. "But, the worry we had that Lantos might be associated with cancer seems not to be the case, and people should continue using insulin," said Dr. Spyros Mezitis, an endocrinologist at Lenox Hill Hospital in New York City, who wasn't involved in these studies.

Lantus is a long-acting insulin, meaning patients need only one shot a day, rather than multiple injections, and it's easy to use, Mezitis added.

People using glargine often have type 1 diabetes, a condition in which the body can't make insulin, which is needed to regulate the amount of sugar in the blood. People with type 2 diabetes, the form linked to being overweight and sedentary, may also take insulin if lifestyle and dietary changes don't control their blood-sugar levels.

In the United States, where obesity and type 2 diabetes are soaring, Mezitis said he expects to see many more insulin users in years to come.

In each study, researchers wanted to see if there was any connection between daily doses of insulin and cancer.

The results were scheduled for presentation Monday at a meeting of the American Diabetes Association in Philadelphia.

In one study, Laurel Habel, a research scientist at the Kaiser Permanente Northern California Division of Research, and colleagues looked at the risk of cancer among 115,000 patients taking either glargine or an intermediate-acting insulin called NPH. This is usually taken twice a day.

"We looked at prostate, breast and colon cancer and all cancers combined," Habel said. "We saw no evidence that there was any relationship between glargine and the risk of these cancers."

In addition, no risk of cancer was noted among patients who switched from another long-acting insulin to glargine or in people who started on glargine first, Habel said.

But, these findings are based on short-term use of the drugs -- median duration was less than 1.5 years -- and she said additional follow-up is needed to evaluate cancer risk over the long-term. Cancer can take years to decades to develop, Habel noted.

In another trial, researchers from the University of North Carolina (UNC) looked at the risk of cancer in more than 52,000 people taking glargine or NPH.

Over two years of follow-up, the researchers found no association between either form of insulin and the risk for any cancer.

The UNC team used data from the Northern European Study of Insulin and Cancer, which included more than 447,000 patients, and found no spike in cancer risk for glargine or any other insulin.

"There was absolutely no association at all between the risk of cancer and any form of insulin," researcher Peter Boyle, president of the International Prevention Research Institute in Lyon, France, said during a Monday press conference. The researchers had looked for risk of all cancers, plus risks for cancers of the breast, lung, pancreas, lung, colon and prostate.

"There was absolutely no causal association," he added.

In yet another study, Dr. Hertzel Gerstein, a professor of medicine at McMaster University in Hamilton, Ontario, Canada, and colleagues found no raised risk of cancer or heart disease in a study of insulin involving more than 12,500 participants.

"At the end of the day, the study showed that one injection of insulin a day had a neutral effect on heart attacks, strokes and deaths. In addition, it had no effect on other outcomes like cancers," Gerstein said.

No protective effects on cardiovascular health or cancer were seen from insulin either, according to the report, published in the June 11 online edition of the New England Journal of Medicine.

Data and conclusions presented at medical meetings should be considered preliminary until published in a peer-reviewed medical journal.

More information

For more information on diabetes, visit the American Diabetes Association.

Copyright c 2012?HealthDay. All rights reserved.

Johnson & Johnson diabetes drug tops older therapies in studies

AppId is over the quota
AppId is over the quota

(Reuters) - An experimental treatment for type 2 diabetes developed by Johnson & Johnson demonstrated greater reduction in blood sugar than Merck & Co's Januvia and an older common treatment, glimepiride, according to data from a pair of late stage clinical trials.

The J&J drug, canagliflozin, also led to significantly greater weight loss than both of the other drugs and far fewer incidents of hypoglycemia, or potentially dangerous drops in blood sugar levels, than glimepiride, a member of the sulfonylurea class of medicines.

Weight loss is an especially attractive effect as obesity is a leading cause of type 2 diabetes and some older medicines cause weight gain.

Canagliflozin, belongs to a new class of diabetes treatments called SGLT2 inhibitors that work by blocking reabsorption of glucose by the kidney and increases glucose excretion in the urine to lower blood sugar.

The data from the two 52-week studies, presented on Saturday at the American Diabetes Association (ADA) meeting in Philadelphia, are part of a massive approval application J&J submitted to the U.S. Food and Drug Administration last week that comprised nine separate Phase III trials involving more than 10,000 patients. If approved it would be the giant healthcare conglomerate's first diabetes medicine.

"There are clearly some unmet needs in diabetes to get glucose control. Hypoglycemia is a big limitation and right now we don't have effective weight loss therapy, so this class of drugs clearly provides clinical benefits," said Dr. William Cefalu, the primary researcher on the glimepiride study.

"This would be another viable option, another tool in the tool box," Cefalu said of canagliflozin.

In the 755-patient study comparing 300 milligram once-daily canagliflozin to Januvia, the J&J drug provided statistically significant reductions in A1C levels -- a commonly used measure of blood sugar over time.

Canagliflozin led an average drop in A1C levels of 1 percent compared with a drop of 0.6 percent for Januvia, a DPP4 inhibitor known chemically as sitagliptin. Some 47 percent of canagliflozin patients got A1C down to the ADA guideline of 7 or less compared with 35 percent of Januvia patients, J&J said.

The J&J drug led to an average weight loss of 2.5 percent, or about 2.3 kilograms (5 pounds) compared with virtually no impact on weight for the Merck drug. The weight loss for canagliflozin was even more pronounced in the other study.

Patients in the study were already taking metformin -- the most common first treatment option after diet and exercise fails -- and a sulfonylurea.

The rate of hypoglycemia was similar and over 40 percent for both groups, likely largely due to the solfonylureas, which have been associated with high rates of hypoglycemia.

More patients dropped out of the study due to loss of glycemic control in the Januvia group -- 22.5 percent versus 10.6 percent. The rate of serious side effects was low and similar for both drugs, but discontinuation due to serious side effects was higher for canagliflozin -- 5.3 percent vs 2.9 percent.

STRIKING WEIGHT LOSS

The 1,450-patient canagliflozin versus glimepiride trial studied two doses of the J&J drug -- 100 mg and 300 mg -- in subjects already on maximally effective doses of metformin.

A1C reductions were nearly identical for glimepiride and the lower dose of the J&J drug. The 300 mg dose proved to be statistically superior with an average A1C reduction of 0.93 pct compared with 0.81 for glimepiride.

Glimepiride patients on average added about 1 percent to their weight after 52 weeks. The 100 mg canagliflozin led to a 4.2 percent weight reduction and there was a 4.7 percent weight reduction for 300 mg patients, or a difference of about 10 pounds (4.5 kg) versus the older drug.

There was also a big difference in incidence of hypoglycemia in the study. The percentage of patients with at least one episode of hypoglycemia was 4.9 for 300 mg dapagliflozin, 5.6 percent for 300 mg and 34.2 percent for glimepiride.

Aside from glucose control, "the other striking thing was the weight loss and the lack of hypoglycemia," said Cefalu, head of diabetes at the Pennington Biomedical Research Center at Louisiana State University.

In both studies, the J&J drug led to increases in both good and bad cholesterol and a small but favorable decrease in blood pressure.

Canagliflozin was also associated with higher rates of genital infections, urinary tract infections and need for increased urination.

Researchers, however, did not run into concerns over liver damage that contributed to the FDA rejection of dapagliflozin, a drug from AstraZeneca and Bristol-Myers Squibb that belongs to the same class as the J&J drug.

"We reported some favorable reduction in liver enzymes," Cefalu said.

(Reporting By Bill Berkrot; Editing by Bernard Orr)

Health Tip: What to Expect After Childbirth

AppId is over the quota
AppId is over the quota

(HealthDay News) -- If you've just given birth, it's important to relax, enjoy your new baby and take care of yourself.

The womenshealth.gov website offers these suggestions for brand-new moms:

Don't try to lose a lot of weight too quickly.Focus on eating healthy, nutritious foods.When your doctor says it's ok, start a regular exercise routine.Be on the lookout for signs of "baby blues," medically called postpartum depression.Be patient as you transition to life with your new baby.Some women develop a post-birth thyroid problem, which could include symptoms such as lack of energy and difficulty sleeping.

Copyright c 2012?HealthDay. All rights reserved.

Wednesday, June 20, 2012

The rediscovered hyperthermia therapy of cancer

In the treatment of prostate cancer, a method is very successful, the so-called turf (Transurethral radio frequency therapy). For the treatment of cancer hyperthermia, uses a specific device, additional heat in an electric field of short radio waves is built.Short radio waves have the advantage to be less harmful to the healthy tissue that the previous used microwave ovens. Also short radio waves have a higher range.From hyperthermia inserts a catheter through the urethra, which carries a probe on. This probe sends short radio waves through the prostate tissue. The receivers are fixed to the thighs. Because of radiowaves which prostate tissue is heated, the spacecraft itself remains cold, avoiding injury to urethra.

Effect of hyperthermiaBecause of cancer cells of the primitive blood supply (compared with normal cells) may bring forth evil heat. Cancer cells that causes congestion of heat, which leads to under the provision of oxide.This is a symptom of deficiency disorders of important metabolic processes for prolieferation and repairsystems cells precipitate. So dead cells cannot be replaced, the consequence is that the cancer will die. Hyperthermia can be combined with radiotherapy or chemicaltherapy. This combination has proven to be effective, because even after treatment with chemo or radiation cancer can recover and be resistant to radiation and cytostatic. Heat cancercells hyperthermia DNA will be severely damaged. Cancer has no chance to regenerate. The temperature of Transurethral hyperthermia is roughly 48A° C 52A° C/° F° f 118A to 126A. Hyperthermia therapy is an experimental cancertherapy.

History of hyperthermiaFirst cited was the heeling effect of the ancient Egyptians (2400 BC), but physicians of ancient Greece have this therapeutic approach applied and named: overheating (Greece: Hyperthermie).Through the centuries many illnesses were fought with generation of fever with the help of pyrogen. This encroachments into the body and bodyfunction can call active hyperthermia. The passive hyperthermia is increased using a device from bodytemperature out. A pioneer of modern "Fevertherapy" Julius Wagner von Jauregg is that observed in a patient with random "Erysipel", which gets the healing because of the plague. Later, he developed the fevertherapy employing blood infected with malaria, also called "Malariatherapy". Von Jauregg won the Nobel Prize in medicine for the treatment of lues using "fevertherapy". The procedure has lost its importance with the rise of antibioticaltherapy, but is now rediscovered therapy as a cancer therapy.

This article was written by ErOn UG in partnership with a cancer expert from Hanover, Germany.

Use and distribution of this article is subject to our Publisher guidelines
whereby the original author and copyright information must be included.

Sanofi's Lantus shows no cancer, heart risks: study

AppId is over the quota
AppId is over the quota

PARIS (Reuters) - Sanofi's insulin Lantus does not put people at risk of cancer, heart attacks or strokes when taken over long periods, according to a major study in which the drug failed to prove it can prevent heart disease in early-stage diabetics.

Although a positive result on heart disease could have widened Lantus's use, the findings of the longest and largest study of its kind should help shake off safety concerns about the French group's top-selling drug after a 2009 cancer scare.

A number of studies at the time suggested a possible link between Lantus and a heightened risk of cancer, with conflicting results.

"We know what the risks are of taking insulin on a long-term basis, and they are low," said the principal investigator of the trial, Hertzel Gerstein of McMaster University in Ontario, Canada, in a telephone interview with Reuters.

The closely watched study also found that people with pre-diabetes who received daily Lantus injections had a 28 percent lower chance of developing diabetes, even after the injections stopped.

The study tested more than 12,500 people at risk or in the early stages of diabetes with either a daily injection of Lantus or standard therapy for an average of six years.

The results confirmed two known side effects of insulin - low blood sugar levels and modest weight gain. Researchers said these were minor reactions.

The study also discovered that daily doses of Lovaza, a prescription pill based on fish oil and sold by Pronova Biopharma and GlaxoSmithKline, did not prevent heart-related deaths in diabetics.

The findings were presented on Monday at the American Diabetes Association congress in Philadelphia, U.S., and published online in the New England Journal of Medicine.

STUDY EXTENDED

Paris-based Sanofi said it would extend the study by two years to gather further data on Lantus.

Worldwide, Lantus has 80 percent of the market for long-acting, or basal, insulin used to treat diabetes, generating sales of around 3.9 billion euros ($4.9 billion) last year, representing 12 percent of Sanofi's total sales.

Sanofi is particularly reliant on Lantus because it faces a wave of patent expirations on other blockbuster medicines.

Fresh competition is emerging as rival drugmakers, such as U.S. group Eli Lilly and Danish company Novo Nordisk, prepare to launch newer long-acting insulin, in addition to the threat of biosimilars.

The insulin market is also vulnerable to the growth of GLP-1 therapies, including Sanofi's own Lyxumia, which is in late stage development.

(Reporting by Elena Berton; Editing by Dan Lalor)

Health Highlights: June 6, 2012

AppId is over the quota
AppId is over the quota

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:

Sheryl Crow Has Benign Brain Tumor

After being diagnosed with a benign brain tumor, singer-songwriter Sheryl Crow described it as a "bump in the road" and told fans not to worry about her.

"Please don't worry about my 'brain tumor,' it's a noncancerous growth. I know some folks can have problems with this kind of thing, but I want to assure everyone I'm OK," Crow wrote on her Facebook page, CNN reported.

She was diagnosed with meningioma a few months ago. She doesn't require surgery for this common type of brain tumor but will have periodic brain scans to monitor its growth.

"It's a tumor that typically grows between the outer layer of the brain and the brain itself. So it's not actually inside the brain," explained CNN Chief Medical Correspondent and neurosurgeon Sanjay Gupta.

Depending on the size, some people have this type of tumor removed immediately while others may never need surgery or treatment, Gupta said.

Crow is a breast cancer survivor.

-----

'Pink Slime' Rejected by Most School Districts

A beef product widely referred to as "pink slime" is off the menu in most school districts across the United States.

The vast majority of states that participate in the National School Lunch Program have decided to order ground beef that doesn't contain the filler product known as lean finely textured beef, the U.S. Department of Agriculture said.

The USDA said only three states -- Iowa, Nebraska and South Dakota -- ordered beef that may contain the filler, the Associated Press reported.

After a public outcry early this year, the USDA said in March that it would change its policy and offer schools the choice to purchase beef without the filler for the 2012-13 school year.

Lean finely textured beef is made of fatty beef chunks that are heated and then treated with ammonia to kill bacteria. The USDA says it's a safe, affordable and nutritious product, the AP reported.

-----

Settlement Close in Listeria Outbreak Lawsuits: Lawyers

A settlement may be pending in lawsuits against a Colorado farm identified as the source of last fall's listeria outbreak that involved cantaloupes and caused at least 30 deaths and sickened 146 people in 28 states, lawyers said Monday.

The lawsuits were filed against Jensen Farms by people who became ill or had a family member die in the United States' deadliest outbreak of foodborne illness in 25 years, the Associated Press reported.

A deal could be finalized by fall, according to attorneys for both sides. The settlement could also include a company that did a safety audit of the farm and a company that makes and imports food-processing equipment, said Bill Marler, a lawyer for 39 of the plaintiffs.

The proposed settlement under discussion would establish a victims' fund of $4 million, the AP reported.

The outbreak was likely caused by dirty water on the floor and old, difficult-to-clean equipment, according to the U.S. Food and Drug Administration.

Copyright c 2012?HealthDay. All rights reserved.

Superbug gonorrhea spreading across Europe

AppId is over the quota
AppId is over the quota

LONDON (Reuters) - "Superbug" strains of gonorrhea which are becoming untreatable accounted for almost one in 10 cases of the sexually transmitted disease in Europe in 2010, more than double the rate of the year before, health officials said on Monday.

The drug-resistant strains are also spreading fast across the continent, officials warned. They were found in 17 European countries in 2010, seven more than in the previous year.

Gonorrhea was the second most common sexually transmitted infection (STI) in Europe in 2010, with more than 32,000 infections, data from the Stockholm-based European Centre for Disease Prevention and Control (ECDC) showed.

Even though chlamydia was the most frequently reported STI, with more than 345,000 cases, the ECDC's director singled out gonorrhea as presenting a "critical situation".

Marc Sprenger said the increase in cases of superbug strains meant there was a risk gonorrhea may become an untreatable disease in the near future.

The proportion of gonorrhea cases with resistance to the antibiotic recommended to treat the disease, cefixime, rose from 4 percent in 2009 to 9 percent in 2010.

The ECDC report follows a warning from the World Health Organisation that virtually untreatable forms of drug-resistant gonorrhea were spreading around the world.

Gonorrhea is a bacterial infection which, if left untreated, can lead to pelvic inflammatory disease, ectopic pregnancies, stillbirths, severe eye infections in babies, and infertility in men and women.

VIGILANT

It is one of the most common sexually transmitted diseases in the world and is most prevalent in South and Southeast Asia and sub-Saharan Africa.

In the United States alone, the number of cases is estimated at about 700,000 a year, according to the Centers for Disease Control and Prevention (CDC).

The emergence of drug-resistant gonorrhea is caused by unregulated access to and overuse of antibiotics, which help fuel genetic mutations within the bacteria.

"Public health experts and clinicians need to be aware of the current critical situation and should be vigilant for treatment failures," Sprenger said in a statement.

Experts say the best way to reduce the risk of even greater resistance developing - beyond the urgent need to develop new drugs - is to rapidly and accurately diagnose the disease and then treat it with combinations of two or more types of antibiotics at the same time.

This technique is used in the treatment of some other infections like tuberculosis in an attempt to make it more difficult for the bacteria to learn how to overcome the drugs.

The ECDC's sexually transmitted infections report covered data and trends on five STIs - syphilis, congenital syphilis, gonorrhea, chlamydia and lymphogranuloma venereum (LGV) - in the EU and European Economic Area from 1990 to 2010.

It found diverging trends in sexually transmitted diseases across Europe, with a rapidly increasing trend for chlamydia and slightly decreasing trends for gonorrhea and syphilis.

Genital chlamydia infections are caused by Chlamydia trachomatis bacteria which can irreversibly damage a woman's reproductive organs.

Although the disease is easily treated with antibiotics, infections can remain undiagnosed because many patients - 70 percent of women and 50 percent of men - have no symptoms and so are unaware they are carrying and passing on the infection.

(Editing by Pravin Char)

Georgia student with flesh-eating infection OKs more amputations

AppId is over the quota
AppId is over the quota

ATLANTA (Reuters) - A Georgia college student fighting a rare flesh-eating bacterial infection mouthed "Let's do this" when told that her hands and remaining foot would have to be amputated, her father said on Friday.

Andy Copeland, Aimee Copeland's father, wrote in a Facebook posting that a doctor told the family on Thursday that "the hands were endangering Aimee's progress."

He said he told the doctors, "Do whatever it takes to give us the best chance to save Aimee's life."

Copeland then took his daughter's hands and, holding them up to her face, said, "Aimee, these hands are not healthy. They are hampering your progress."

He continued, "Your mind is beautiful, your heart is good and your spirit is strong. These hands can prevent your recovery from moving forward. The doctors want to amputate them and your foot today to assure your best possible chance of survival."

Aimee Copeland smiled, raised her hands and mouthed "Let's do this," her father wrote.

She was listed in critical condition on Friday, said Barclay Bishop, a spokeswoman for Doctors Hospital in Augusta, Georgia. Bishop declined to say whether doctors had amputated the hands and foot.

Copeland, 24, was kayaking and zip-lining along the Little Tallapoosa River near Carrollton, Georgia, on May 1 when the line broke and she cut her calf.

Emergency-room doctors closed the wound with 22 staples and released Copeland, a graduate student at West Georgia University.

But after her condition worsened, Copeland was diagnosed with necrotizing fasciitis, a bacterial infection that can destroy muscles, skin and tissue.

Surgeons amputated her left leg at the hip and struggled to save her hands and remaining foot.

Two other cases of flesh-eating infections have been reported recently in South Carolina. A new mother of twins in Greenville, Lana Kuykendall, 36, was in critical but stable condition on Thursday at Greenville Memorial Hospital, a hospital spokeswoman said.

And a former South Carolina fire chief, Glenn Pace, told a local television station he had been battling the disease since early April and had three surgeries on his foot.

Different bacteria can cause necrotizing fasciitis. The "flesh-eating" infection is not communicable.

(Editing By Cynthia Johnston and Xavier Briand)

Florida bingo set will go for safest net-but whose?

AppId is over the quota
AppId is over the quota

BONITA SPRINGS, Florida (Reuters) - Bill James, a retired state trooper and resolute Republican, knows what he wants from a presidential candidate: "Fix the economy, straighten out the budget, do something about the national debt."

But when it comes to curbing Medicare costs, a prime driver of the nation's deficit, James doesn't favor any cutback.

Should the ballooning federal insurance program be revamped? "Only if I got approximately the same benefits and paid approximately the same amount of money," said the 77-year-old, who is battling bone cancer.

Medicare and Social Security, the massive programs that pay benefits to tens of millions of older Americans, are contentious issues in the 2012 presidential campaign. Seniors want the nation's sputtering economy to be fixed, but not at their expense.

In the midterm elections two years ago, one in five voters were over 65. If older Americans turn out in force this year, they could swing the presidential race. President Barack Obama and his GOP opponent, Mitt Romney, are neck and neck in current surveys.

In a nationwide Reuters/Ipsos poll, 42 percent of seniors said they would vote for Romney and 39 percent for Obama if the election were held today. Among other voters, the two candidates were even.

However, when asked which party better serves the needs of Americans over 65, Democrats edged out Republicans among seniors by 34 percent to 31 percent.

CONFLICTING MESSAGES

As was the case in 2010, strident rhetoric, partisan distortions and ugly ad campaigns are sowing confusion over programs that serve the elderly.

"There's only one president in history who has cut Medicare by $500 billion - and that's Barack Obama," Mitt Romney tells voters. (In fact, Medicare spending would continue to grow under Obama's plan.)

A conservative group, AmericanDoctors4Truth, launched an ad campaign in March that showed Obama pushing an old lady in a wheelchair off a cliff. The spot, which ran in Florida and Texas, mimicked a 2011 video by a liberal group that showed Republican Representative Paul Ryan of Wisconsin, author of a Medicare privatization plan, rolling a disabled senior down a steep hill.

Romney has endorsed Ryan's legislation to steer future retirees to private health insurance, which was adopted by the GOP-controlled House earlier this year, along with a cap on Medicare spending.

Obama contends that the Romney-backed plan would "end Medicare as we know it," telling an Ohio rally last month, "We're not going to go back to the days when our citizens spent their golden years at the mercy of private insurance companies."

In Limetree Park, a Gulf Coast mobile home community where James and his wife, Rosalie, spend the winter, the ideology of residents ranges from far left to far right. But all agree on one thing: the importance of an adequate federal safety net.

"We couldn't survive without Medicare," said Rosalie James. At 78, the former switchboard operator has had two knee replacements and is being treated for diabetes and heart disease.

Two doors away, Andrea Davis, 63, a former secretary, said she hadn't worked long enough at one place to build up a 401(k). "If it weren't for Social Security, I would probably be on the street," she added.

BINGO, BILLIARDS AND BIBLE STUDY

On a sunny afternoon in Limetree, men in shorts play shuffleboard; women in floral bathing suits lounge around the pool. Activities are posted on a board at the barbecue pavilion. Monday: poker and dominoes. Tuesday: bingo and billiards. Wednesday: koffee klatch and Bible study.

An entrance sign at the 240-unit park greets visitors with the motto "Finding friendship in paradise." To preserve harmony, Limetree retirees say they rarely talk politics with their neighbors.

In the Reuters/Ipsos poll, 32 percent of seniors said Obama has better plans for Social Security and Medicare, while 30 percent said Romney does.

"Rich seniors are better served by the GOP, while the policies of the Democrat party are slanted toward the middle class," said Mark Findlay, 67, a retired Pennsylvania businessman who spends winters at Limetree. "But ... Tea Party members don't seem to realize it."

Bill Bontrager, who lives a few doors away on Golden Sand Avenue, sees it differently. A Tea Party sympathizer and Romney supporter, he wants fewer government regulations, lower taxes and spending cuts to fix the deficit.

Including cuts to Social Security and Medicare benefits? No, that's not what Bontrager, 68, has in mind. "It is very irritating when they say these are entitlements," he complained. "How can something be an entitlement when you've paid for it your whole life?"

DEFICITS AHEAD

In fact, American workers and retirees are not paying enough for either Social Security or Medicare to remain solvent.

Obama and Romney agree that the programs must be changed, but they differ sharply on how to do it.

With 78 million baby boomers entering retirement, Social Security is set to run short of money by 2037, according to government actuaries. The projected deficit: roughly $87 billion a year.

Romney favors a plan, popular in the business community, to partly privatize Social Security by directing the contributions of future retirees into 401(k)-type investment accounts. Obama opposes the idea, saying it would subject retirement savings “to the whims of the stock market.” In the Reuters/Ipsos poll, seniors disagreed with the idea by 46 percent to 25 percent.

Romney would also raise the retirement age for full Social Security benefits beyond 67 and would gradually boost the eligibility age for Medicare until it matches life expectancy. These "commonsense reforms," he says, would help "save Social Security and Medicare for future generations."

Obama has backed away from proposals to postpone benefits, which would be unpopular among blue-collar voters with arduous jobs.

"I blew out my knees, my feet and my shoulder with construction work," said Limetree resident Dewey Schilling, 62, who survives on Social Security disability benefits. "If you work till you're 70, you ain't got a whole lot of life left to enjoy."

Instead, Obama, along with many Democrats, would replenish Social Security by lifting the current cap on the payroll tax, so that income above $110,100 a year would no longer be exempt.

THE 'MEDISCARE' STAMPEDE

Lifting the cap is anathema to Republicans who vow not to raise taxes, but it taps into a growing public sentiment that the rich are not paying their fair share.

"They need to change the tax structure," said Jeanne Cross, 82, a former receptionist who votes Republican. "All these people making all this money, they're not paying as much taxes as you and I."

Bontrager, the Tea Party sympathizer, disagrees. He once owned an Indiana factory that made truck bodies and employed 135 people. The tax-the-rich rhetoric is foolhardy, he said. "Have you ever seen a poor man create a job?"

In the 2010 midterm elections, Republican assertions that the Patient Protection and Affordable Care Act, passed by Congress and dubbed Obamacare, would slash Medicare benefits and institute "death panels" to ration care set off a stampede to the polls by furious seniors.

In 2008, 16 percent of voters were over 65, but two years later that proportion had jumped by five points. The power of what pundits called Mediscare helped the GOP recapture control of the House and gain six seats in the Senate.

In the next decade, spending for the giant insurance program is set to nearly double, from $576 billion to $1.05 trillion a year, because of the rising cost of medical care and the aging of the population. By 2030 the number of Americans on Medicare will jump from 49 million to 79 million.

Obama's healthcare reform law doesn't cut senior benefits. In fact, it expands preventive care and prescription coverage for the elderly. It would slow Medicare spending by curbing payments to nursing homes and other health facilities, penalizing error-prone hospitals, speeding generic drugs to market, and boosting premiums for wealthier retirees.

Overall, it would cut the projected rise in per capita Medicare costs from 6.8 percent to 5.5 percent over 10 years, for a net savings of $428 billion by 2019.

WIDESPREAD CONFUSION

That estimate has given Romney an opening to accuse Obama of cutting healthcare for seniors. Obama, meanwhile, calls the GOP-supported budget and Medicare plan "a radical vision" and "thinly veiled social Darwinism."

A TV spot launched in Florida and other swing states last month shows a young Obama with his grandparents and touts his administration's recovery of $4 billion from healthcare scam artists who prey on seniors.

The Reuters/Ipsos poll revealed the whipsaw effect of conflicting messages: Sixty-one percent of seniors disapproved of the Obamacare law. But they were evenly split on whether Obama or Romney has a better plan for healthcare.

In Limetree Park, confusion is widespread. Stan Brummel, 69, a retired Michigan toolmaker, voted for Obama in 2008. Now he's on the fence. Obama is the one trying to cut Medicare, said Brummel, who suffers from polymyalgia.

Like many of his neighbors, Brummel was unfamiliar with the Ryan plan to restructure Medicare, which, as it happens, retains the very savings in Medicare spending that were enacted under Obamacare and that GOP candidates have attacked.

The House-passed premium support plan, endorsed by Romney, would give seniors vouchers to buy private insurance beginning in 2022, gradually replacing government-run Medicare. The goal: market competition to drive down costs.

Last year the nonpartisan Congressional Budget Office calculated that if Medicare fully transitioned to private insurance plans, as proposed in the 2011 House-passed budget, it would more than double seniors' out-of-pocket costs, to $12,500 a year. That measure died in the Senate.

This year's version retains traditional Medicare as an option. It is co-authored by Senator Ron Wyden of Oregon, a Democrat, but most Democratic lawmakers oppose it because it could allow premiums to rise.

COMFORT FACTOR

At Limetree, Ruth Hoeger, a retired nurse, knows the value of a safety net more than most. Her father was a coal miner who died of black lung disease when she was 11; Hoeger and her siblings survived on Social Security.

Now she and her husband live with a 45-year-old son who receives Social Security disability payments for chronic pulmonary disease. A former carpenter, he was exposed to asbestos.

Hoeger, 74, fears the Romney Medicare plan. "I've got arthritis and high blood pressure. What insurance company would cover me for the price of the voucher?" she asks. "If you privatize Medicare, the elderly will die earlier."

Her neighbor, Bontrager, thinks the privatization plan might be a good idea. "What happens to the money we pay into Medicare?" he asks. "It is mismanaged. The government should get out of the insurance industry."

As the campaign heats up, the intricacies of how to slash the deficit and reform entitlements seem unlikely to lend themselves to nuanced discussion.

Beyond the charges and countercharges, however, many older Americans are fully aware that how the safety net is designed can mean the difference between poverty and a comfortable life in a place such as Limetree Park.

They'll be paying keen attention before casting their votes in November.

(This is the third article to run as part of American Mosaic, a yearlong Reuters/Ipsos polling and reporting project that focuses on the diverse groups and competing views at play in the 2012 presidential race. The data is drawn primarily from online surveys using sampling methods developed in consultation with outside experts. By Election Day the survey will have reached 150,000 people, mixing respondents recruited from the Internet with individuals screened by Ipsos. Their responses are weighted based on demographic information and refined using a monthly telephone poll. With this method, accuracy is measured using a statistical calculation called a credibility interval. To see all the data from this survey and other polls in the series, go to www.reuters.com/politics/american-mosaic.)

(Editing by Lee Aitken, Prudence Crowther and Douglas Royalty)